Abstract
Planning to give the right drug with the right dose to the right patient is mandatory for a successful application of intravenous anaesthesia. Making sure that this dose will be delivered to the patient at all times in the course of an anaesthetic procedure is of equal importance. This requires knowledge of the infusion device and how to control it. It requires thoughtful setup of infusion systems including the lines to avoid disturbances in the flow of the drug to the patient. As no system can be guaranteed to be fail-safe, back up plans need to be available to cope with situations not expected when starting the anaesthesia. In addition, inexperienced clinicians who use intravenous techniques need to be properly trained and educated. In this chapter, syringe driving infusion pumps will be discussed in general but particularly in relation to target (TCI) and effect target-controlled infusion (ETCI). Issues to be discussed include the effect of occlusions and alarm settings and how to connect the syringe to the patient. Possible pitfalls caused by, for example, dead space in the infusion line and how to deal with situations like a failing TCI system or an inadvertently reset or not reset TCI device will be addressed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Peterfreund RA, Philip JH (2013) Critical parameters in drug delivery by intravenous infusion. Exp Opin Drug Deliv. 10(8):1095–108. doi:10.1517/17425247.2013.785519.
Struys MMRF, De-Smet T, Glen JIB, Vereecke HEM, Absalom AR, Schnider TW. The history of target-controlled infusion. Anesth Analg. 2016;122(1):56–69. doi:10.1213/ANE.0000000000001008.
Schraag S, Flaschar J. Delivery performance of commercial target-controlled infusion devices with diprifusor module. Eur J Anaesthesiol. 2002;19(5):357–60. doi:10.1017/S0265021502000571.
Sarraf E, Mandel JE. Time-delay when updating infusion rates in the Graseby 3400 pump results in reduced drug delivery. Anesth Analg. 2014;118(1):145–50. doi:10.1213/01.ane.0000438349.21617.2f.
Engbers FHM. Total intravenous anaesthesia: the equipment. In: Vuyk J, Mulder S, Engbers F, editors. On the study and practice of intravenous anaesthesia. Dordrecht: Kluwer Academic Publishers; 2000. p. 71–81.
Chiou WL. Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination. J Pharmacokinet Biopharm. 1979;7:527–36.
Glen JIB, Engbers FHM. The influence of target concentration, equilibration rate constant (ke0) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion. Anaesthesia. 2016;71(3):306–14. doi:10.1111/anae.13345.
Chan E, Hubbard A, Sane S, Maa Y-F. Syringe siliconization process investigation and optimization. J Pharm Sci Technol. 2012;66(2):136–50. doi:10.5731/pdajpst.2012.00856.
Schulz G, Fischer J, Neff T, Bänziger O, Weiss M. The effect of air within the infusion syringe on drug delivery of syringe pump infusion systems. Anaesthesist. 2000;49(12):1018–23.
Kern H, Kuring A, Redlich U, Döpfmer UR, Sims NM, Spies CD, Kox WJ. Downward movement of syringe pumps reduces syringe output. Br J Anaesth. 2001;86(6):828–31.
McCarroll C, McAtamney D, Taylor R. Alteration in flow delivery with antisyphon devices. Anaesthesia. 2000;55(4):355–7.
Sundaram R, Dell AE. Interaction between infusion equipment resulting in drug overdose in a critically ill patient. Anaesthesia. 2005;60(1):88–91. doi:10.1111/j.1365-2044.2004.04012.x.
Lannoy D, Décaudin B, Dewulf S, Simon N, Secq A, Barthélémy C, et al. Infusion set characteristics such as antireflux valve and dead-space volume affect drug delivery: an experimental study designed to enhance infusion sets. Anesth Analg. 2010;111(6):1427–31. doi:10.1213/ANE.0b013e3181f66ee3.
Lovich MA, Doles J, Peterfreund RA. The impact of carrier flow rate and infusion set dead-volume on the dynamics of intravenous drug delivery. Anesth Analg. 2005;100(4):1048–55. doi:10.1213/01.ANE.0000146942.51020.88.
Lovich MA, Kinnealley ME, Sims NM, Peterfreund RA. The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume. Anesth Analg. 2006;102(4):1147–53. doi:10.1213/01.ane.0000198670.02481.6b.
Rieschke P, LaFleur BJ, Janicki PK. Effects of EDTA- and sulfite-containing formulations of propofol on respiratory system resistance after tracheal intubation in smokers. Anesthesiology. 2003;98(2):323–8.
Muller AE, Huisman I, Roos PJ, Rietveld AP, Klein J, Harbers JBM, Dorresteijn JJ, van Steenbergen JE, Vos MC. Outbreak of severe sepsis due to contaminated propofol: lessons to learn. J Hosp Infect. 2010;76(3):225–30.
Cole DC, Baslanti TO, Gravenstein NL, Gravenstein N. Leaving more than your fingerprint on the intravenous line: a prospective study on propofol anesthesia and implications of stopcock contamination. Anesth Analg. 2015;120(4):861–7. doi:10.1213/ANE.0b013e318292ed45.
Nakao M, Yamanaka S, Iwata M, Nakashima M, Onji I. [The cracks of polycarbonate three-way stopcocks are enhanced by the lubricating action of fat emulsion of propofol]. Masui. 2003;52(11):1243–7.
Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ. The influence of age on propofol pharmacodynamics. Anesthesiology. 1999;90(6):1502–16.
Absalom AR, Mani V, De Smet T, Struys MMRF. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail. Br J Anaesth. 2009;103(1):26–37. doi:10.1093/bja/aep143.
Engbers FH, Sutcliffe N, Kenny G, Schraag S. Pharmacokinetic models for propofol: defining and illuminating the devil in the detail. Br J Anaesth. 2010;104(2):261–2, author reply 262–4. doi:10.1093/bja/aep385.
Dawson PJ, Bjorksten AR, Blake DW, Goldblatt JC. The effects of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam. Yjcan. 1997;11(5):556–61. doi:10.1016/S1053-0770(97)90003-3.
Peeters MYM, Bras LJ, DeJongh J, Wesselink RMJ, Aarts LPHJ, Danhof M, Knibbe CAJ. Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients. Clin Pharmacol Ther. 2008;83(3):443–51. doi:10.1038/sj.clpt.6100309.
Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth. 2002;12(3):205–19.
Donmez A, Araz C, Kayhan Z. Syringe pumps take too long to give occlusion alarm. Pediatr Anesth. 2005;15(4):293–6. doi:10.1111/pan.2005.15.issue-4.
Absalom A. Accuracy of the “Paedfusor” in children undergoing cardiac surgery or catheterization. Br J Anaesth. 2003;91(4):507–13. doi:10.1093/bja/aeg220.
Kataria BK, Ved SA, Nicodemus HF, Hoy GR, Lea D, Dubois MY, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology. 1994;80(1):104–22.
Knibbe CAJ, Zuideveld KP, Aarts LPHJ, Kuks PFM, Danhof M. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults. Br J Clin Pharmacol. 2005;59(6):705–11. doi:10.1111/j.1365-2125.2005.02239.x.
Greeley WJ, de Bruijn NP, Davis DP. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg. 1987;66(11):1067–72.
Iwakiri H, Nishihara N, Nagata O, Matsukawa T, Ozaki M, Sessler DI. Individual effect-site concentrations of propofol are similar at loss of consciousness and at awakening. Anesth Analg. 2005;100(1):107–10. doi:10.1213/01.ANE.0000139358.15909.EA.
McGlone and Peck. Bulletin RCoA 91, 2015. p. 47–9. https://www.rcoa.ac.uk/system/files/CSQ-Bulletin91_1.pdf. Accessed 11 Mar 2016.
Barvais L, Lobo FA, Engbers FHM, Irwin MG, Schnider TW, Schraag S. Tips and tricks to optimize total intravenous anesthesia. Acta Anaesthesiol Belg. 2013;64(4):137–46.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Engbers, F. (2017). Pump Pitfalls and Practicalities. In: Absalom, A., Mason, K. (eds) Total Intravenous Anesthesia and Target Controlled Infusions. Springer, Cham. https://doi.org/10.1007/978-3-319-47609-4_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-47609-4_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-47607-0
Online ISBN: 978-3-319-47609-4
eBook Packages: MedicineMedicine (R0)